International product information

The product details shown after you switch describe the versions of Rho authorized outside the United States, including the Rho Score, which is not part of the US version.

US product information

The product details shown after you switch describe the version of Rho authorized in the United States, which reports whether a patient is Rho Positive.

Request a demo →
For imaging networks

Turn existing X-ray volume into DXA referrals that confirm disease.

For operators, radiology leaders and administrators. Rho flags patients who may have low bone density in the plain films your sites read, for the referring clinician.

A general radiography room with an X-ray table, wall stand and ceiling-mounted tube
Measured value

More DXAs, and more of them confirm low bone density.

Results from a before-and-after comparison over 13 months at one eight-site Ontario imaging provider, 34,162 X-rays analyzed.

  • 1.8×

    Increase in initial DXAs after radiologists began reporting Rho findings. Surveillance DXAs rose 1.4×.1

  • 87% vs 69%

    DXAs prompted by Rho found low bone density more often than DXAs arranged through usual care.1

  • 83% vs 45%

    Men aged 65 and older, a group usual care often misses: 83% of DXAs prompted by a Rho finding confirmed low bone density, against 45% of DXAs arranged through usual care. First-ever DXAs: 84% vs 60%.1

  1. 1 Syme et al., Skeletal Radiology, 2026 ↗: a before-and-after comparison at one eight-site Ontario imaging provider
How the referral happens

No new exam. No new step for technologists.

Rho works on images acquired for other reasons. The only visible change is a Rho Report in PACS for flagged studies, which the radiologist can choose to include in their report.

  1. 01

    Routine X-ray

    A patient aged 50 or older has a frontal chest, thoracic spine, lumbar spine, pelvis, hand or wrist, or knee X-ray for any reason.

  2. 02

    Rho screens it

    Rho analyzes the image inside your network and, for flagged studies, sends a Rho Report to PACS.

  3. 03

    Radiologist reports

    The radiologist can include the finding in the report, with a simple dictation macro or through PowerScribe or HL7 integration.

  4. 04

    DXA follows

    The referring clinician assesses fracture risk and may order a DXA. When the scanner is yours, that exam stays in your network.

Rho Console

Track your ROI.

An IT administrator or clinical user can open the Rho Console in a browser on the same network: which X-rays were analyzed, whether a report was sent, and when a Rho-screened patient returns for DXA.

Cases

Sample data
From2026-05-01 To2026-10-12 Show lastToday3d1w1m SexAll Age50 to 120 Study typeAll X-ray
Studies (patients) 3,214 2,987 patients
High risk patients 1,402 47% of patients
DXA follow-ups 286 20% of high risk patients
Sex Female 62%Male 38%
X-ray type
  • Chest 41%
  • Knee 17%
  • Lumbar spine 13%
  • Hand 11%
  • Pelvis 10%
  • Thoracic spine 8%
Rho-generated DXAs by month
Inferences
X-ray date Rho ID Accession no. Patient ID Sex X-ray type Rho result Time to DXA (months) Inference Report sent
2026-10-09 3214 A-48213 P-20931 F Chest Positive 8 N/A ✓ ✓
2026-10-09 3213 A-48207 P-18822 M Knee Not Positive 3 N/A ✓ –
2026-10-08 3209 A-48190 P-20117 F Lumbar Positive 7 N/A ✓ ✓
2026-07-14 2411 A-41022 P-15540 F Hand Positive 9 1.8 ✓ ✓
2026-06-02 1987 A-37311 P-13002 M Thoracic Not Positive 6 3.1 ✓ ✓
2026-05-21 1840 A-36120 P-12471 F Pelvis Positive 7 2.4 ✓ ✓
Operations

Built to roll out across a network.

Light IT lift

One on-premise virtual machine on your existing infrastructure and standard DICOM routing from PACS. No new logins for radiologists and no new technologist steps. Installation and configuration usually take about an hour.

Matched to DXA capacity

Each institution can set the Rho Score threshold for sending reports, by body part and sex, to match local DXA capacity. Only Rho Positive reports are sent to PACS by default, so radiologists see a report only for flagged studies.

Data stays on site

Rho is designed so that images and patient data stay in your environment, which keeps security review straightforward.

Guideline-aligned screening at scale

Rho prompts the clinical fracture-risk assessment that is recommended but often overlooked, in patients likely to benefit.2,3,4

  1. 2 BHOF 2022 (LeBoff et al., Osteoporosis International) ↗
  2. 3 USPSTF 2025 (Nicholson et al., JAMA) ↗
  3. 4 Osteoporosis Canada 2023 (Morin et al., CMAJ) ↗
Economics

Who pays for opportunistic screening?

Rho is licensed as software, priced on gross annual X-ray volume. The return comes from DXA exams that would otherwise not have been ordered.

Model the DXA return for your network →
  • Existing imaging

    Rho runs on X-rays taken for another reason. There is no new exam to order or bill.

  • Downstream DXA

    Rho increases appropriate DXA referrals, which are reimbursed in many markets (in the US, Medicare Part B covers DXA for eligible patients5). When DXA capacity is in your network, that demand stays with you. In the study above, initial DXAs rose 1.8×.1

  • Self-pay markets

    Where DXA is self-pay, Rho flags patients for assessment from their existing X-rays.

  • Licensing

    An annual software license based on gross X-ray volume. Ask us for a quote for your sites.

  1. 1 Syme et al., Skeletal Radiology, 2026 ↗: a before-and-after comparison at one eight-site Ontario imaging provider
  2. 5 Medicare.gov, Bone mass measurements ↗

In clinical and research use at imaging networks, orthopedic groups, and hospitals around the world

See what Rho finds in your network.

We will walk through your X-ray volume, DXA capacity, and reporting setup, and show how Rho fits each site.

For healthcare professionals

The information on this page is intended for healthcare professionals. Please confirm that you are a healthcare professional to continue.

Take me to patient information